Anti-Cancer Upstart’s Stock Surges 125% This Year as Billionaire Druckenmiller Builds Large Position Jul 18, 2026 Life Science
Raising Dividends for 54 Consecutive Years to Reward Shareholders, Abbott Laboratories’ Diversified Layout Consolidates Its Growth Foundation Jul 17, 2026 Life Science
UnitedHealth Group Stock Rises 37% Year-to-Date, Market Sees Path Back to All-Time Highs Jul 16, 2026 Life Science
Druckenmiller’s $613 Million Silent Bet Is Crushing Nvidia — and It’s Not a Tech Stock Jul 16, 2026 Life Science
Johnson & Johnson Posts Solid Quarter, Yet Wall Street Sells Off – What Spooked Investors? Jul 16, 2026 Life Science
Intuitive Surgical’s Stock Has Fallen Over 25% This Year, but Goldman Sachs Still Recommends Investors Buy Jul 15, 2026 Life Science
Two Overhyped GLP-1 Stocks Present Buying Opportunities on Dips, with Novo Nordisk and Kailera Therapeutics Each Offering Unique Highlights Jul 14, 2026 Life Science
WELL Health Delivers Record Profits — Is This 53% Discount a Buying Opportunity? Jul 14, 2026 Life Science, Technology
The Market Has Responded Coolly to Vertex’s Multibillion-Dollar Acquisition, but Management’s Track Record and Integration Capabilities Add Confidence to the Deal Jul 14, 2026 Life Science
Core Business Steady Growth Coupled with Acquisition Tailwinds, Vertex Pharmaceuticals Demonstrates Strong Post-Market Momentum Jul 11, 2026 Life Science
2026 Top Canadian Stock Investment Outlook, Dual-Track Positioning in Energy and Digital Health Jul 10, 2026 Life Science
Incyte and TG Therapeutics Deliver Notable Growth, Drawing Investment Attention to the Biotech Sector Jul 9, 2026 Life Science
Two Healthcare Blue-Chip Stocks Offer Opportunities as Dividends Shine Bright for Pfizer and Bristol-Myers Squibb Jul 8, 2026 Life Science
Biotech Double Winners Outperform the Market, With Fundamental Tailwinds Poised to Sustain Momentum Jul 7, 2026 Life Science
Eli Lilly Stock Hits Record High as Analysts Bullish on Weight-Loss Drug Market Prospects Jul 7, 2026 Life Science
The Shadow of a Tech Stock Pullback Looms, Jefferies Screens Top Ten Low-Momentum High-Quality Stocks as a Defensive Guide Jul 7, 2026 Life Science, Technology
The $10 Billion Acquisition Is Set, as Vertex Pharmaceuticals Bets on a New Blue Ocean in Rare Endocrine Diseases Jul 7, 2026 Life Science
